Back to top

Multi-Biomarker Assay developed by NALIA Systems for Phase II Clinical Trial

8th May

NALIA Systems is pleased to report the completion of a project in which it successfully developed a multi-biomarker assay for a pharmaceutical company and then used that assay to monitor the levels of several biomarkers in samples from the company’s Phase 2 clinical trial.